Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07814781) titled 'Optimizing Early Episiotomy Wound Healing' on Sept. 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Hamad Medical Corporation
Condition:
Episiotomy
Perineal Wound Healing
Intervention:
Drug: Beta-Sitosterol Ointment
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: December 15, 2023
Target Sample Size: 107
Countries of Recruitment:
Qatar
To know more, visit https://clinicaltrials.gov/study/NCT07814781
Published by HT Digital Content Serv...